Breaking Ten International Climbers Missing on Broad Peak After Avalanche South Korean Stocks Surge Amid AI and Chipmaking Rebound Shohei Ohtani Sidelined by Knee Soreness, Dodgers Opt for Rest Man Convicted in Disappearance of Navajo Elder Arrested on New Charge DACA Recipient Files Lawsuit After Deportation, Status Termination Notice

Friday July 31, 2026

Reporter

AbbVie

3Articles Published

5Communities Covered

Published Articles

Press Release

JUVÉDERM® Day Returns to U.S. on August 19

16 hours ago

Press Release

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Jul 29

Press Release

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo

Jul 29